TrialDiabetes technology & therapeutics2011

Baseline predictors of A1C reduction in adults using sensor-augmented pump therapy or multiple daily injection therapy: the STAR 3 experience.

John B Buse et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.